Oklahoma Pediatric Psychotropic Medication Resource Guide

Page 117

USE OF COMPLEMENTARY AND ALTERNATIVE TREATMENTS (CBD, MELATONIN, AND HERBAL PRODUCTS) GENERAL INFORMATION • Always ask patients and caregivers about any non-prescription products a patient may be taking. Ask specifically about over-the-counter medications, herbal and dietary supplements, and nutraceuticals. • Evaluate medication list of prescription and non-prescription medications for drug-drug, drugdisease, and drug-food interactions that may impact care. • Dietary supplements and herbal products are not FDA-approved and therefore are not regulated by the same rules prescription medications are, increasing chances of product strength variation. SPECIFIC PRODUCTS, CATEGORIES, AND PEARLS • Cannabis and Derivatives: ○ The cannabis plant contains many derivatives; the two most well-known are delta-9tetrahydrocannabidiol (Δ9-THC, or THC) and cannabidiol (CBD).5,11 ○ CBD is most commonly formulated into oil. Ideally this oil would be purely CBD, but most report having some THC too. The maximum allowable amount of THC that can be present in CBD oil sold in the U.S. is 0.3%, or 3 mg/mL.8 ○ THC has been linked to the development of schizophrenia and is a contributor to neurodevelopment deficits in adolescents.3,11 There are no indications for medical marijuana for pediatric patients with mental health disorders, sleep disorders, anxiety, pain or posttraumatic stress disorder.7 ○ We do not recommend the use of medical marijuana in pediatric patients. Both the American Academy of Child and Adolescent Psychiatry and American Academy of Pediatrics opposed marijuana legalization for both medical and recreational use because of the danger to children and adolescents with increased access, decreased perception of harm and increased marijuana use among parents and caretakers.1,2 ○ In a sample of 84 products purchased online, less than 50% of the products had accurate amounts of CBD concentration. Also, THC was detected in 21% of the samples with concentrations as high as 6.43 mg/mL.4 This raises concern about what concentration of CBD and THC a consumer is purchasing without oversight by the FDA. ○ Pure CBD oil has been FDA-approved for Lennox-Gastaut and Dravet syndrome in pediatric patients.16 It is, however, not recommended to prescribe or recommend non-prescription, over-the-counter CBD oil, THC or any other cannabis-derived products for children.

M E D I C I N E . O K S T A T E . E D U

113


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Acknowledgements

2min
pages 121-124

Use of Complementary and Alternative Treatments (CBD, Melatonin and Herbal Products

6min
pages 117-120

Suicidal Ideation

6min
pages 113-116

PTSD and Trauma-Related Disorders 6–17 years

3min
pages 102-104

Intellectual Disability (Early childhood–17 years

9min
pages 88-93

Substance Abuse

6min
pages 107-112

Oppositional Defiant Disorder and Conduct Disorder

3min
pages 99-101

Obsessive Compulsive Disorder (OCD

3min
pages 96-98

Eating Disorders (ages 6–18 years

8min
pages 82-87

Nightmares

1min
pages 94-95

Disruptive Mood Dysregulation Disorder (DMDD

2min
pages 80-81

Depression (6–17 years of age

5min
pages 75-79

Bipolar Disorder

9min
pages 57-62

Autism Spectrum Disorder (Early childhood–17 years

10min
pages 50-56

Discontinuing Medications

1min
page 6

Obsessive Compulsive Disorder (OCD) in Children 0–5

3min
pages 29-31

Post-Traumatic Stress Disorder (PTSD) and Trauma in Children 0–5

4min
pages 32-34

Attachment Disorders (Disinhibited Social Engagement Disorder and Reactive Attachment Disorder) and Related Relationship Problems Ages 0–5

4min
pages 13-16

Disruptive Behavior Disorders in Young Children (i.e. Oppositional Defiant Disorder

3min
pages 25-28

Depression 3–5 years

2min
pages 23-24

Criteria Indicating Further Review

3min
pages 7-9
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.